Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001441557-13-000039
Filing Date
2013-05-13
Accepted
2013-05-13 11:48:23
Documents
1
Period of Report
2013-05-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3795
  Complete submission text file 0001441557-13-000039.txt   5280
Mailing Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095
Business Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095 801-446-8802
OphthaliX, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OPHTHALIX INC. 10 BAREKET ST. PATACH TIKVA L3 49170
Business Address
Weinstein Itay (Reporting) CIK: 0001536175 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 13835993